BSE filing, NSE: BISIL. Summary written from the filing by ALFA Finder's alert engine.
Karnawati Innovation Ltd: key numbers
- Share price
- ₹1.15
- Market cap
- ₹6.21 Cr
- Revenue (annual)
- ₹0.93 Cr
- Net profit (annual)
- ₹0.15 Cr
- P/E (TTM)
- 1.7×Sector 43.1×
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Karnawati Innovation Ltd
All →Karnawati Innovation Board Meeting Date
Karnawati Innovation Limited cancelled its June 5 board meeting as the statutory audit remains ongoing. A revised date for financial results approval will be announced later.
Karnawati Innovation Other Announcement
Karnawati Innovation Limited submitted its Annual Secretarial Compliance Report for the financial year 2026. The report confirms overall adherence to SEBI listing regulations and statutory provisions.
Karnawati Innovation Board Meeting Date
Karnawati Innovation scheduled a board meeting for May 28, 2026, to approve audited financial results. This provides advance notice of upcoming performance disclosures.
Karnawati Innovation Debt & Borrowing
Karnawati Innovation Ltd has disclosed that it does not qualify as a 'Large Corporate' for the financial year ended March 31, 2026, per SEBI norms. The company reported zero outstanding borrowings as of the period end, exempting it from mandatory incremental borrowing requirements through debt securities.
Karnawati Innovation Other Announcement
Karnawati Innovation Limited submitted its quarterly certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations for the period ended March 31, 2026. The registrar, MUFG Intime India, confirmed that security certificates received for dematerialisation were processed and listed on the exchanges within prescribed timelines.
Karnawati Innovation Q3 FY26 Results: Net Profit ₹1.8 Cr, Up 12.5% QoQ
Karnawati Innovation Ltd reported net profit of ₹1.8 Cr for Q3 FY26.
- Key figure
- Net profit ₹1.8 Cr
Other board meeting date announcements
All →Mangalam Drugs and Organics Board Meeting Date
Mangalam Drugs will hold a board meeting on 5 November 2026 to consider unaudited September 2026 quarter results. The agenda is proposed only, pending the meeting.
Shivam Autotech Board Meeting Date
Shivam Autotech has scheduled a board meeting on 04-11-2026 to consider unaudited standalone results for the quarter ended September 2026. The trading window closes from 01-10-2026 to 06-11-2026.
Moneyview Board Meeting Date
Moneyview will hold a board meeting on 5 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year. No financial figures are disclosed in this notice.
Abans Enterprises Board Meeting Date
Abans Enterprises will hold a board meeting on 4 November 2026 to consider unaudited quarterly and half-year results. No financial figures are disclosed in this notice.
Gloster Board Meeting Date
Gloster Ltd will hold a board meeting on 5 November 2026 to consider unaudited standalone and consolidated results for the second quarter. No financial figures are disclosed in this notice.
NRB Bearings Board Meeting Date
NRB Bearings will hold a board meeting on 4 November 2026 to approve Q2 and H1 unaudited results and consider an interim dividend. The trading window stays closed until 9 November 2026.